You have 9 free searches left this month | for more free features.

Venetoclax

Showing 1 - 25 of 485

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Light Chain (AL) Amyloidosis, CCND1 Translocation, Venetoclax Trial (Venetoclax, Dexamethasone Oral)

Not yet recruiting
  • Light Chain (AL) Amyloidosis
  • +2 more
  • Venetoclax
  • Dexamethasone Oral
  • (no location specified)
Aug 16, 2023

AML, MDS Trial in Tuebingen (Decitabine, Venetoclax)

Recruiting
  • AML
  • MDS
  • Tuebingen, Baden-Wuerttemberg, Germany
    University Hospital
Nov 30, 2023

Healthy Volunteers Trial in Grayslake (Venetoclax)

Recruiting
  • Healthy Volunteers
  • Venetoclax
  • Grayslake, Illinois
    Acpru /Id# 259897
Oct 2, 2023

Elderly AML Patients, Unfit, New-diagnosis AML, Acute Myeloid Leukemia Trial in Kunming (Experimental: Venetoclax in combination

Not yet recruiting
  • Elderly AML Patients
  • +4 more
  • Experimental: Venetoclax in combination with Decitabine (+-sorafenib)
  • Active Comparator: Standard dose of Venetoclax + Azacitidine
  • Kunming, Yunnan, China
    The Second Affiliated Hospital of Kunming Medical University.
Oct 3, 2023

Venetoclax Plasma Concentration and Remission in Acute Myeloid

Not yet recruiting
  • Adult Acute Myeloid Leukemia
  • Blood sampling for venetoclax drug dosage (venous puncture)
  • (no location specified)
Sep 13, 2023

Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Chronic Lymphocytic, Small-Cell Lymphoma Trial (Nemtabrutinib, Venetoclax,

Not yet recruiting
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • +5 more
  • (no location specified)
Jul 21, 2023

Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial (Venetoclax)

Not yet recruiting
  • Multiple Myeloma in Relapse
  • Multiple Myeloma, Refractory
  • Venetoclax
  • (no location specified)
Oct 30, 2023

Acute Myeloid Leukemia Refractory Trial in Lyon (NP137, Azacitidine Injection, Venetoclax)

Recruiting
  • Acute Myeloid Leukemia Refractory
  • Lyon, France
    Centre Léon Bérard
Nov 30, 2023

Idiopathic Pulmonary Fibrosis Trial in Birmingham (Venetoclax)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • Venetoclax
  • Birmingham, Alabama
    A. Brent Carter
Aug 3, 2023

CLL Trial (Sonrotoclax, Zanubrutinib, Venetoclax)

Not yet recruiting
  • CLL
  • (no location specified)
Oct 3, 2023

Newly-diagnosed Ph+ Acute Lymphoblastic Leukemia Trial in Xi'an (Olverembatinib plus venetoclax and dexamethasone)

Recruiting
  • Newly-diagnosed Ph+ Acute Lymphoblastic Leukemia
  • Olverembatinib plus venetoclax and dexamethasone
  • Xi'an, Shannxi, China
    Department of Hematology, Xijing Hospital, Fourth Military Medic
Oct 9, 2023

AML/MDS, Acute Myeloid Leukemia, MDS Trial (Danvatirsen, Danvatirsen + Venetoclax)

Not yet recruiting
  • AML/MDS
  • +2 more
  • (no location specified)
Aug 14, 2023

Acute Myeloid Leukemia Trial in Marseille, Nice (Pharmacokinetic sampling, Vital status determination, Toxicity assessments)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Pharmacokinetic sampling
  • +3 more
  • Marseille, France
  • +1 more
Sep 6, 2023

Myeloid Malignancy, Acute Myeloid Leukemia Trial in Cleveland (Venetoclax, Decitabine)

Not yet recruiting
  • Myeloid Malignancy
  • Acute Myeloid Leukemia
  • Cleveland, Ohio
    University Hospitals Seidman Cancer, Case Comprehensive Cancer C
Nov 8, 2023

Hypomethylating Agent, Venetoclax, Myeloid Malignancy Trial in Shanghai (Venetoclax, Azacitidine or decitabine)

Recruiting
  • Hypomethylating Agent
  • +2 more
  • Venetoclax
  • Azacitidine or decitabine
  • Shanghai, Shanghai, China
    Shanghai Jiao Tong University School of Medicine Affilated Shang
May 2, 2023

Healthy Volunteers Trial in Grayslake (Venetoclax)

Recruiting
  • Healthy Volunteers
  • Venetoclax
  • Grayslake, Illinois
    Acpru /Id# 255783
Jun 21, 2023

Acute Myeloid Leukemia Trial in Beijing (Ven+CAG)

Recruiting
  • Acute Myeloid Leukemia
  • Beijing, Beijing, China
    Peking University People's Hospital
Jun 23, 2023

Acute Myeloid Leukemia Trial (Dasatinib)

Not yet recruiting
  • Acute Myeloid Leukemia
  • (no location specified)
Sep 20, 2023

Mantle Cell Lymphoma Refractory Trial (Ibrutinib, Venetoclax, Navitoclax)

Not yet recruiting
  • Mantle Cell Lymphoma Refractory
  • (no location specified)
May 16, 2023

Relapsed Adult AML, Refractory AML Trial in Milwaukee (Navitoclax Dose Level -1, Navitoclax Dose Level 0, Navitoclax Dose Level

Not yet recruiting
  • Relapsed Adult AML
  • Refractory AML
  • Navitoclax Dose Level -1
  • +10 more
  • Milwaukee, Wisconsin
    Froedtert Hospital & the Medical College of Wisconsin
Aug 17, 2023

Multiple Myeloma, Multiple Myeloma in Relapse Trial (Belantamab mafodotin, Venetoclax)

Not yet recruiting
  • Multiple Myeloma
  • Multiple Myeloma in Relapse
  • Belantamab mafodotin, Venetoclax
  • (no location specified)
May 10, 2023

Chronic Myelomonocytic Leukemia Trial in Houston (Azacitidine, Tamibarotene, Venetoclax)

Not yet recruiting
  • Chronic Myelomonocytic Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Oct 10, 2023

Diffuse Large B Cell Lymphoma Trial (Venetoclax, Carmustine, Cytarabine)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • Venetoclax
  • +5 more
  • (no location specified)
May 9, 2023

Acute Myeloid Leukemia Trial in Suzhou (Venetoclax, Homoharringtonine, Cytarabine)

Recruiting
  • Acute Myeloid Leukemia
  • Venetoclax
  • +2 more
  • Suzhou, Jiangsu, China
    Qiu Huiying
Mar 28, 2023

AML, Adult, Minimal Residual Disease Trial (MRD assessment)

Not yet recruiting
  • AML, Adult
  • Minimal Residual Disease
  • MRD assessment
  • (no location specified)
Oct 13, 2023